Screening for polycystic ovary syndrome (PCOS) in antenatal care is inadequate, largely
owing to the lack of clarity around whether PCOS is an independent risk factor for pregnancy …

Inositols are insulin-sensitizing compounds of promising efficacy in the management of
polycystic ovary syndrome (PCOS). On the one hand, myo-inositol (myo-ins) plays a …

Oxidative stress (OS) is a condition that occurs as a result of an imbalance between the
production of reactive oxygen species (ROS) and the body's ability to detoxify and neutralize …

Background Clinical guidelines rely on sound evidence to underpin recommendations for
patient care. Compromised research integrity can erode public trust and the credibility of the …

Psychotropic drug–related weight gain (PDWG) is a common occurrence and is highly
associated with non-initiation, discontinuation, and dissatisfaction with psychiatric drugs …

Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder
affecting females across the lifespan. Eating disorders (EDs) are psychiatric conditions that …

Polycystic ovary syndrome (PCOS), characterized by abnormal menstrual periods, elevated
androgen levels and polycystic ovary morphology on ultrasound, is the most common …

Polycystic ovary syndrome (PCOS) affects about 12% of women of reproductive age. In
2018, the first evidence‐based guideline on assessment and management of PCOS was …

Metformin is best known as a foundational therapy for type 2 diabetes but is also used in
other contexts in clinical medicine with a number of emerging and potential indications …

Objectives To examine the global prevalence of polycystic ovary syndrome (PCOS) among
adolescents across world regions, comparing the 2003 Rotterdam consensus criteria with …